Αρχική World News 177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic... World News 177Lu-DOTATATE Shows Promising Efficacy in the Treatment of Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas Από Ogkologos - 2 Σεπτεμβρίου, 2025 310 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Phase II study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Want to learn more about Sulforaphanes? 4 Δεκεμβρίου, 2020 ΚΑΡΚΙΝΟΣ ΕΝΔΟΜΗΤΡΙΟΥ 10 Φεβρουαρίου, 2019 Immunotherapy Plus Chemotherapy Helps People With Advanced Nasopharyngeal Cancer: The ASCO... 18 Απριλίου, 2022 A New Online Tool Predicts RFS and OS Probabilities in Patients... 7 Φεβρουαρίου, 2024 Φόρτωση περισσοτέρων HOT NEWS MAP Congress 2020: Molecular Analysis for Precision Oncology Female Breast Cancer is Now the Most Commonly Diagnosed Cancer in... EMA Recommends Granting a Marketing Authorisation for Quizartinib Divarasib in Combination with Cetuximab Demonstrates a Manageable Safety Profile and...